Influence of a single course of antenatal betamethasone on the maternal-fetal insulin-IGF-GH axis in singleton pregnancies

Growth Hormone and IGF Research

Volumn 16, Issue 4, 2006, Pages 267-275

  Ahmad, Irfan ^a,b   Beharry, Kay D A ^a   Valencia, Arwin M ^b   Cho, Steve ^b   Guajardo, Leonel ^b   Nageotte, Michael P ^b   Modanlou, Houchang D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MILLER CHILDREN S HOSPITAL   (United States)

Author keywords

Betamethasone; Growth hormone; Insulin; Insulin like growth factors; Maternal; Umbilical cord

Indexed keywords

BETAMETHASONE; GLUCOSE; GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; INSULIN; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ANTHROPOMETRY; ARTICLE; BIRTH WEIGHT; BLOOD ANALYSIS; BLOOD SAMPLING; BODY SIZE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DELIVERY; FEMALE; FETOPLACENTAL UNIT; HUMAN; HYPOTHESIS; MATERNAL BLOOD; NEWBORN; NEWBORN MORBIDITY; NEWBORN PERIOD; OBSERVATIONAL STUDY; PREGNANCY; PREMATURE LABOR; PRENATAL CARE; PRIORITY JOURNAL; SINGLE DRUG DOSE; TREATMENT OUTCOME; UMBILICAL CORD BLOOD;

BETAMETHASONE; BIRTH WEIGHT; BLOOD GLUCOSE; FEMALE; FETAL BLOOD; GESTATIONAL AGE; GROWTH HORMONE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MATERNAL-FETAL EXCHANGE; PILOT PROJECTS; PLACENTA; PREGNANCY; PREGNANCY OUTCOME; PREMATURE BIRTH; PRENATAL CARE; TIME FACTORS;

EID: 33748209565     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2006.06.004     Document Type: Article

References (37)

1. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. Effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 273 (1995) 413-418.
2. ACOG Committee Opinion. Antenatal corticosteroids therapy for fetal maturation. American College of Obstetricians and Gynecologists. Int. J. Gynaecol. Obstet. 78 (2002) 95-97
3. Liggins G.C., and Howie R.N. A controlled trial of antepartum glucocorticoid treatment for prevention of RDS in premature infants. Pediatrics 50 (1972) 515-525
4. Crowley P. Antenatal corticosteroid therapy: a metaanalysis of the randomized trials - 1972-1994. Am. J. Obstet. Gynecol. 173 (1995) 322-335
5. McNamara M.F., and Bottoms S.F. The incidence of respiratory distress syndrome does not increase when preterm delivery occurs greater than 7 days after steroid administration. Aust. N. Z. J. Obstet. Gynaecol. 38 (1998) 8-10
6. Banks B., Cnaan A., Morgan A., Parer J., Merril J., Ballard P., et al. North American Thyrotropin-Releasing Hormone Study Group. Multiple courses of antenatal corticosteroids and outcome of premature neonates. Am. J. Obstet. Gynecol. 181 (1999) 709-717
7. McEnvoy C., Bowling S., Williamson K., Collins J., Tolaymat L., and Maher J. Timing of antenatal corticosteroids and neonatal pulmonary mechanics. Am. J. Obstet. Gynecol. 183 (2000) 895-899
8. Newnham J.P., and Moss T.J. Antenatal glucocorticoids and growth: single versus multiple doses in animal and human studies. Semin. Neonatol. 6 (2001) 285-292
9. Vermillion S.T., Soper D.E., and Newman R.B. Neonatal sepsis and death after multiple courses of antenatal betamethasone therapy. Am. J. Obstet. Gynecol. 183 (2000) 810-814
10. Abbasi S., Hirsch D., Davis J., Tolosa J., Stouffer N., Debbs R., et al. Effect of single versus multiple courses of antenatal corticosteroids on maternal and neonatal outcome. Am. J. Obstet. Gynecol. 182 (2000) 1243-1249
11. Bloom S.L., Sheffield J.S., McIntire D.D., and Levano K.J. Antenatal dexamethasone and decreased birth weight. Obstet. Gynecol. 97 (2001) 485-490
12. Jobe A.H., Wada N., Berry L.M., Ikegami M., and Ervin M.G. Single and repetitive glucocorticoid exposures reduce fetal growth in sheep. Am. J. Obstet. Gynecol. 178 (1998) 880-885
13. Ikegami M., Polk D.H., and Jobe A.H. Minimum interval from fetal betamethasone treatment to postnatal lung response in preterm lambs. Am. J. Obstet. Gynecol. 174 (1996) 1408-1418
14. McKenna D.S., Wittber G.M., Nagaraja H.N., and Samuels P. The effects of repeat doses of antenatal corticosteroids on maternal adrenal function. Am. J. Obstet. Gynecol. 183 (2000) 669-673
15. Barker D.J., Eriksson J.G., Forsen T., and Osmond C. Fetal origins of adult disease: strength of effects and biological basis. Int. J. Epidemiol. 31 (2002) 1235-1239
16. Fant M.E., and Weisoly D. Insulin and Insulin-like growth factors in human development: implications for the perinatal period. Semin. Perinatol. 25 (2001) 426-435
17. Giudice L.C., de Zegher F., Gargosky S.E., Dsupin B.A., de las Fuentes L., Crystal R.A., et al. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J. Clin. Endocrinol. Metab. 80 (1995) 1548-1555
18. McIntyre H.D., Serek R., Crane D.I., Veveris-Lowe T., Parry A., Johnson S., et al. Placental growth hormone (GH), GH-binding protein, and insulin-like growth factor axis in normal, growth-retarded, and diabetic pregnancies: correlations with fetal growth. J. Clin. Endocrinol. Metab. 85 (2000) 1143-1150
19. Boyne M.S., Thame M., Bennett F.I., Osmond C., Miell J.P., and Forrester T.E. The relationship among circulating insulin-like growth factor (IGF)-I, IGF-binding proteins-1 and -2, and birth anthropometry: a prospective study. J. Clin. Endocrinol. Metab. 88 (2003) 1687-1691
20. Pirazzoli P., Cacciari E., De Iasio R., Pittalis M.C., Dallacasa P., Zucchini S., et al. Developmental pattern of fetal growth hormone, insulin-like growth factor I, growth hormone binding protein and insulin-like growth factor binding protein-3. Arch. Dis. Child. 77 (1997) F100-F104
21. Moss T.J., Doherty D.A., Nitsos I., Slobada D.M., Harding R., and Newnham J.P. Effects into adulthood of single or repeated antenatal corticosteroids in sheep. Am. J. Obstet. Gynecol. 192 (2005) 146-152
22. Aghajafari F., Murphy K., Matthews S., Ohlsson A., Amankwah K., and Hanna M. Repeated doses of antenatal corticosteroids in animals: a systematic review. Am. J. Obstet. Gynecol. 186 (2002) 843-849
23. Agarwal R., Chiswick M.L., Rimmer S., Taylor G.M., McNally R.J., Alston R.D., et al. Antenatal steroids are associated with a reduction in the incidence of cerebral white matter lesions in very low birthweight infants. Arch. Dis. Child. Fetal. Neonatal. Ed. 86 (2002) F96-F101
24. Kumar P., and Seshadri R. Neonatal morbidity and growth in very low birth-weight infants after multiple courses of antenatal steroids. J. Perinatol. 25 (2005) 698-702
25. Dalziel S.R., Walker N.K., Parang V., Mantell C., Rea H.H., Rodgers A., et al. Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomized controlled trial. Lancet 365 (2005) 1856-1862
26. Pagano G., Bruno A., Cavallo-Perin P., Cesco L., and Imbimbo B. Glucose intolerance after short-term administration of corticosteroids in healthy subjects. Prednisone, deflazacort and betamethasone. Arch. Intern. Med. 149 (1989) 1098-1101
27. Ballard P.L., Gluckman P.D., Liggins G.C., Kaplan S.L., and Grumbach M.M. Steroid and growth hormone levels in premature infants after prenatal betamethasone therapy to prevent respiratory distress syndrome. Pediatr. Res. 14 (1980) 122-127
28. Gluckman P.D., Sizonenko S.V., and Bassett N.S. The transition from fetus to neonate - an endocrine perspective. Acta. Paediatr. Suppl. 428 (1999) 7-11
29. Li J., Owens J.A., Owens P.C., Saunders J.C., Fowden A.L., and Gilmore R.S. The ontogeny of hepatic growth hormone receptor and insulin-like growth factor I gene expression in the sheep fetus during late gestation: developmental regulation by cortisol. Endocrinology 137 (1996) 1650-1657
30. Miell J.P., Taylor A.M., Jones J., Holly J.M., Gaillard R.C., Pralong F.P., et al. The effects of dexamethasone treatment on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteers. J. Endocrinol. 136 (1993) 525-533
31. Ogueh O., Miell J.P., Jones J.C., Jones J.S., Alaghband-Zadeh J., and Johnson M.R. Antenatal dexamethasone and the growth hormone-insulin-like growth factor axis. Hum. Reprod. 15 (2000) 1403-1406
32. Chellakooty M., Vangsgaard K., Larsen T., Scheike T., Falck-Larsen J., Legarth J., et al. A longitudinal study of intrauterine growth and the placental growth hormone (GH)-insulin-like growth factor I axis in maternal circulation: association between placental GH and fetal growth. J. Clin. Endocrinol. Metab. 89 (2004) 384-391
33. Mesiano S., Katz S.L., Lee J.Y., and Jaffe R.B. Insulin-like growth factors augment steroid production and expression of steroidogenic enzymes in human fetal adrenal cortical cells: implications for adrenal androgen regulation. J. Clin. Endocrinol. Metab. 82 (1997) 1390-1396
34. Mesiano S., and Jaffe R.B. Role of growth factors in the developmental regulation of the human fetal adrenal cortex. Steroids 62 (1997) 62-72
35. Coulter C.L., Ross J.T., Owens J.A., Bennett H.P., and McMillen I.C. Role of pituitary POMC-peptides and insulin-like growth factor II in the developmental biology of the adrenal gland. Arch. Physiol. Biochem. 110 (2002) 99-105
36. Coulter C.L., Goldsmith P.C., Mesiano S., Voytek C.C., Martin M.C., Han V.K., et al. Functional maturation of the primate fetal adrenal in vivo: I. Role of insulin-like growth factors (IGFs), IGF-I receptor, and IGF binding proteins in growth regulation. Endocrinology 137 (1996) 4487-4498
37. Peaceman A.M., Bajaj K., Kumar P., and Grobman W.A. The interval between a single course of antenatal steroids and delivery and its association with neonatal outcomes. Am. J. Obstet. Gynecol. 193 (2005) 1165-1169